Salient Capital Advisors’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
VAM
MNA
IUHSA
Salient Capital Advisors's ABEV Position: Q3 2017 in Review
Salient Capital Advisors sold out of Ambev (ABEV) in Q3 2017, closing a stake of 82,587 shares — an estimated $453K sold.
Salient Capital Advisors first reported a position in ABEV in Q1 2014 and held it in 14 quarters. The position peaked at $1.59M in Q2 2016. 312 funds tracked by Wall St. Rank hold ABEV as of Q3 2017.
- Salient Capital Advisors reported no remaining Ambev position as of Q3 2017 after selling out during the quarter.
- Salient Capital Advisors sold 82,587 Ambev shares in Q3 2017, an estimated $453K.
- Salient Capital Advisors first reported a position in Ambev in Q1 2014 and held it in 14 quarters.
- Salient Capital Advisors's Ambev position peaked at $1.59M in Q2 2016.
- 312 funds tracked by Wall St. Rank held Ambev as of Q3 2017.
Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.